Miyauchi A. Chronology of thyroid Cancer. World J Surg. 2023;47(2):288–95. https://doi.org/10.1007/s00268-022-06741-4.

Article  PubMed  Google Scholar 

Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg. 2014;140:317–22. https://doi.org/10.1001/jamaoto.2014.1.

Article  PubMed  Google Scholar 

Davies L, Morris LG, Haymart M, Chen AY, Goldenberg D, Morris J, Ogilvie JB, Terris DJ, Netterville J, Wong RJ, Randolph G, AACE Endocrine Surgery Scientific Committee. American association of clinical endocrinologists and american college of endocrinology disease state clinical review: the increasing incidence of thyroid cancer. Endocr Pract. 2015;21:686–96. https://doi.org/10.4158/EP14466.DSCR. PMID: 26135963.

Article  PubMed  PubMed Central  Google Scholar 

Ito Y, Uruno T, Nakano K, Takamura Y, Miya A, Kobayashi K, Yokozawa T, Matsuzuka F, Kuma S, Kuma K, Miyauchi A. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid. 2003;13:381–7. https://doi.org/10.1089/105072503321669875.

Article  PubMed  Google Scholar 

Shaha AR, Tuttle RM, Editorial. Risk of disease progression during active surveillance of papillary thyroid cancer. Surgery. 2018;163:53–4. https://doi.org/10.1016/j.surg.2017.08.020.

Article  PubMed  Google Scholar 

Tuttle RM, Zhang L, Shaha A. A clinical framework to facilitate selection of patients with differentiated thyroid cancer for active surveillance or less aggressive initial surgical management. Expert Rev Endocrinol Metab. 2018;13:77–85. https://doi.org/10.1080/17446651.2018.1449641.

Article  PubMed  PubMed Central  Google Scholar 

National Cancer Institute. Cancer Stat Facts: thyroid cancer. SEER. 2018. Available from: https://seer.cancer.gov/statfacts/html/thyro.html.

Harach HR, Franssila KO, Wasenius VM. Occult papillary carcinoma of the thyroid. A normal finding in Finland. A systematic autopsy study. Cancer. 1985;56:531–8. https://doi.org/10.1002/1097-0142(19850801)56:33.0.CO;2-3.

Article  PubMed  Google Scholar 

Ottino A, Pianzola HM, Castelletto RH. Occult papillary thyroid carcinoma at autopsy in La Plata, Argentina. Cancer. 1989;64:547–51. https://doi.org/10.1002/1097-0142(19890715)64:2<547::aid-cncr2820640232>3.0.co;2-n.

Article  PubMed  Google Scholar 

Lee YS, Lim H, Chang HS, Park CS. Papillary thyroid microcarcinomas are different from latent papillary thyroid carcinomas at autopsy. J Korean Med Sci. 2014;29:676–9. https://doi.org/10.3346/jkms.2014.29.5.676.

Article  PubMed  PubMed Central  Google Scholar 

Kovács GL, Gonda G, Vadász G, Ludmány E, Uhrin K, Görömbey Z, Kovács L, Hubina E, Bodó M, Góth MI, Szabolcs I. Epidemiology of thyroid microcarcinoma found in autopsy series conducted in areas of different iodine intake. Thyroid. 2005;15:152–7. https://doi.org/10.1089/thy.2005.15.152.

Article  PubMed  Google Scholar 

Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L. 2015 american thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid Cancer: the american thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid Cancer. Thyroid. 2016;26:1–133. https://doi.org/10.1089/thy.2015.0020.

Article  PubMed  PubMed Central  Google Scholar 

Mehanna H, Al-Maqbili T, Carter B, Martin E, Campain N, Watkinson J, McCabe C, Boelaert K, Franklyn JA. Differences in the recurrence and mortality outcomes rates of incidental and nonincidental papillary thyroid microcarcinoma: a systematic review and meta-analysis of 21 329 person-years of follow-up. J Clin Endocrinol Metab. 2014;99:2834–43. https://doi.org/10.1210/jc.2013-2118. PMID: 24828487.

Article  PubMed  Google Scholar 

Wada N, Duh QY, Sugino K, Iwasaki H, Kameyama K, Mimura T, Ito K, Takami H, Takanashi Y. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg. 2003;237:399–407. https://doi.org/10.1097/01.SLA.0000055273.58908.19].

Article  PubMed  PubMed Central  Google Scholar 

Ito Y, Miyauchi A, Kihara M, Higashiyama T, Kobayashi K, Miya A. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid. 2014;24:27–34. https://doi.org/10.1089/thy.2013.0367.

Article  PubMed  PubMed Central  Google Scholar 

Sugitani I, Toda K, Yamada K, Yamamoto N, Ikenaga M, Fujimoto Y. Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World J Surg. 2010;34:1222–31. https://doi.org/10.1007/s00268-009-0359-x.

Article  PubMed  Google Scholar 

Sakai T, Sugitani I, Ebina A, Fukuoka O, Toda K, Mitani H, Yamada K. Active surveillance for T1bN0M0 papillary thyroid carcinoma. Thyroid. 2019;29:59–63. https://doi.org/10.1089/thy.2018.0462.

Article  PubMed  Google Scholar 

Tuttle RM, Fagin JA, Minkowitz G, Wong RJ, Roman B, Patel S, Untch B, Ganly I, Shaha AR, Shah JP, Pace M, Li D, Bach A, Lin O, Whiting A, Ghossein R, Landa I, Sabra M, Boucai L, Fish S, Morris LGT. Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance. JAMA Otolaryngol Head Neck Surg. 2017;143:1015–20. https://doi.org/10.1001/jamaoto.2017.1442.

Article  PubMed  PubMed Central  Google Scholar 

Smulever A, Pitoia F. Active surveillance in papillary thyroid carcinoma: not easily accepted but possible in Latin America. Arch Endocrinol Metab. 2019;63:462–9. https://doi.org/10.20945/2359-3997000000168. PMID: 31482955.

PubMed  PubMed Central  Google Scholar 

Smulever A, Pitoia F. High rate incidence of post-surgical adverse events in patients with low-risk papillary thyroid cancer who did not accept active surveillance. Endocrine. 2020;69(3):587–95. https://doi.org/10.1007/s12020-020-02310-8. PMID: 32328966.

Article  PubMed  Google Scholar 

Sanabria A, Kowalski LP, Shah JP, Nixon IJ, Angelos P, Williams MD, Rinaldo A, Ferlito A. Growing incidence of thyroid carcinoma in recent years: factors underlying overdiagnosis. Head Neck. 2018;40:855–66. https://doi.org/10.1002/hed.25029. PMID: 29206325.

Article  PubMed  Google Scholar 

Miyauchi A, Ito Y, Fujishima M, Miya A, Onoda N, Kihara M, Higashiyama T, Masuoka H, Kawano S, Sasaki T, Nishikawa M, Fukata S, Akamizu T, Ito M, Nishihara E, Hisakado M, Kosaka K, Hirokawa M, Hayashi T. Long-term outcomes of active Surveillance and Immediate surgery for adult patients with low-risk papillary thyroid Microcarcinoma: 30-Year experience. Thyroid. 2023;33(7):817–25. https://doi.org/10.1089/thy.2023.0076.

Article  PubMed  PubMed Central  Google Scholar 

Cho SJ, Suh CH, Baek JH, Chung SR, Choi YJ, Chung KW, Shong YK, Lee JH. Active surveillance for small papillary thyroid Cancer: a systematic review and Meta-analysis. Thyroid. 2019;29(10):1399–408. https://doi.org/10.1089/thy.2019.0159.

Article  PubMed  Google Scholar 

Saravana-Bawan B, Bajwa A, Paterson J, McMullen T. Active surveillance of low-risk papillary thyroid cancer: a meta-analysis. Surgery. 2020;167(1):46–55. https://doi.org/10.1016/j.surg.2019.03.040.

Article  PubMed  Google Scholar 

Aryanti C, Sudarsa IW, Adiputra PAT. Meta Analysis of the Outcomes in doing active Surveillance and Surgical Approach for Micropapillary thyroid carcinoma. Asian Pac Environ Cancer. 2022;4(1):25–31. https://doi.org/10.31557/APJEC.2021.4.1.25.

Article  Google Scholar 

Issa PP, Munshi R, Albuck AL, Omar M, Abu Alhuda RF, Metz T, Hussein M, Shama M, Lee GS, Toraih E, Kandil E. Recommend with caution: a meta-analysis investigating papillary thyroid carcinoma tumor progression under active surveillance. Am J Otolaryngol. 2023;44(6):103994DOI. https://doi.org/10.1016/j.amjoto.2023.103994.

Article  Google Scholar 

Brito JP, Ito Y, Miyauchi A, Tuttle RM. A clinical Framework to facilitate risk stratification when considering an active Surveillance Alternative to Immediate Biopsy and surgery in Papillary Microcarcinoma. Thyroid. 2016;26:144–9. https://doi.org/10.1089/thy.2015.0178.

Article  PubMed  PubMed Central  Google Scholar 

Sugitani I, Ito Y, Takeuchi D, Nakayama H, Masaki C, Shindo H, Teshima M, Horiguchi K, Yoshida Y, Kanai T, Hirokawa M, Hames KY, Tabei I, Miyauchi A. Indications and strategy for active surveillance of adult low-risk papillary thyroid Microcarcinoma: Consensus statements from the Japan Association of endocrine surgery Task Force on Management for Papillary thyroid Microcarcinoma. Thyroid. 2021;31(2):183–92. https://doi.org/10.1089/thy.2020.0330.

Article  PubMed  PubMed Central  Google Scholar 

Pitoia F, Miyauchi A. 2015 American Thyroid Association Guidelines for Thyroid Nodules and Differentiated Thyroid Cancer and Their Implementation in Various Care Settings. Thyroid 2016; 26: 319–321. https://doi.org/10.1089/thy.2015.0530.

Groopman J, Hartzband P. Your medical mind. How to decide what is right for you. New York: Penguin Books; 2011. p. 308.

Google Scholar 

Pitoia F, Smulever A. Vigilancia activa encubierta y los costos de la ausencia de implementación de la cirugía diferida en Argentina. Rev Argent Endocrinol Metab. 2020;57(3):40–3.

Google Scholar 

Tong M, Li S, Li Y, Li Y, Feng Y, Che Y. Efficacy and safety of radiofrequency, microwave and laser ablation for treating papillary thyroid microcarcinoma: a systematic review and meta-analysis. Int J Hyperthermia. 2019;36(1):1278–86. https://doi.org/10.1089/thy.2019.0707.

Article  PubMed  Google Scholar 

Ledesma-Leon T, Solis-Pazmino P, Lincango EP, Figueroa LA, Ellenhorn J, Nasseri Y, Cohen J, Romero-Arenas M, Garcia C, Sanabria A, Rojas T, Torres-Román J, Camacho E, Vallejo S, Alvarado-Mafla B, Dream S, James BC, Ponce OJ, Sharma A, Brito JP. Ablation techniques or active surveillance compared to surgical resection in patients with low-risk papillary thyroid cancer: a systematic review and meta-analysis. Endocrine. 2023 Sep 2. https://doi.org/10.1007/s12020-023-03502-8. Epub ahead of print.

Pitoia F, Smulever A. Active surveillance in low risk papillary thyroid carcinoma. World J Clin Oncol. 2020;11(6):320–36. https://doi.org/10.5306/wjco.v11.i6.320.

Article  PubMed  PubMed Central  Google Scholar 

Miyauchi A, Ito Y. Conservative Surveillance Management of low-risk papillary thyroid microcarcinoma. Endocrinol Metab Clin North Am. 2019;48:215–26. https://doi.org/10.1016/j.ecl.2018.10.007.

Article  PubMed  Google Scholar 

Ito Y, Miyauchi A, Kihara M, Fukushima M, Higashiyama T, Miya A. Overall survival of papillary thyroid carcinoma patients: a Single-Institution Long-Term Follow-Up of 5897 patients. World J Surg. 2018;42(3):615–22. https://doi.org/10.1007/s00268-018-4479-z.

Article  PubMed  PubMed Central